About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? [email protected]

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

24 Hour IOP Lowering Efficacy of AL-3789

NCT00643669·1 site·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Lead

Alcon Research

Age

18–any

Sex

ALL

Healthy volunteers

Not accepted

You may be eligible if

Diagnosis of open-angle glaucoma and treated for at least 30 days prior to Screening Visit with a topical prostaglandin analog as monotherapy.

You may not be if

Pregnant, intend to become pregnant, breastfeeding.
Difference in IOP greater than 3 mm Hg between eyes at Screening Visit.
Any form of glaucoma other than open-angle glaucoma.

The record

StatusCompleted

PhasePhase 2

Taking part25

StartedFeb 2008

UpdatedNov 29, 2012

Conditions

Open-angle Glaucoma

Where1

Inglewood
Inglewood, California, United States

Clareo Health | 24 Hour IOP Lowering Efficacy of AL-3789